Vol. 7 (04) pp. 1601-1607 DOI: 10.21474/IJAR01/8989

AGE AS AN INDEPENDENT PROGNOSTIC FACTOR IN BREAST CANCER.

, and
  • Department of surgery, Alexandria faculty of medicine.
  • Department of clinical oncology, Alexandria faculty of medicine.
23 Downloads 108 Views
Crossref

Download Full Paper (PDF)

Abstract

Introduction:Breast cancer is the commonest cancer among females in both developed and developing countries [1]. In the field of breast cancer, in most of the articles, young woman is defined to be below the age of 35 or the age of 40 [2].The results of the National Population-Based Cancer Registry Program in Egypt, showed that, among females, the proportion of breast cancer was 32 % of all female cancers [3]. In study applied in Gharbia over 10 years (1999-2008), the result was that the majority of breast cancer cases during the study period were diagnosed among women aged 40 ? 49 years (31.8%) and among women aged 50?59 years (29.8%) [4] one decade younger than the corresponding age in western countries. Patients and methods:This was a retrospective study in which the records of patients presenting with breast carcinoma who were admitted to the unit of Surgical Oncology and to the Clinical Oncology and Nuclear Medicine department, Alexandria Main University Hospital from January 2000 to December 2009 were collected. Results: There was higher incidence of hormone positive tumors in older patients with a significant difference statistically (p 0.001 for ER receptors and p 0.010 for PR receptors). there is a significant reduction in the disease-free survival (p <0.001) and overall survival (p <0.001) in patient who developed breast cancer before 40 years. Conclusion: Hormone-positive tumors are more common in patients older than 40 years which may indicate a better prognosis in this age group.Younger age at diagnosis of breast cancer is an adverse prognostic factor for relapse of the disease even when effective adjuvant therapy is given. This based on disease free survival and overall survival are worse in young age group.

Keywords

Article Analytics

References

  1. Monica M Rivera-Franco and Eucario Leon-Rodriguez. Delays in Breast Cancer Detection and Treatment in Developing Countries. Breast Cancer: Basic and Clinical Research Volume 12: 1?5.
  2. Courtney A Gabriel and Susan M Domchek. Breast cancer in young women. Breast Cancer Research 2010, 12:212.
  3. Ibrahim AM, Khaled HM, Mikhail NN, Baraka H, KamerH.Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program. J Cancer Epidemiol 2014;2014:1-18.
  4. Hirko KA, Soliman AS, Hablas A, Seifeldin IA, Ramadan M, Banerjee M, et al. Trends in breast cancer incidence rates by age and stage at diagnosis in Gharbiah, Egypt, over 10 Years (1999?2008). J Cancer Epidemiol 2013;2013:916394.
  5. Omar S, Khaled H, Gaafar R, Zekry AR, Eissa S, el-Khatib O. Breast cancer in Egypt: a review of disease presentation and detection strategies. East Mediterr Health J 2003;9(3):448-63.
  6. Schlichting JA, Soliman AS, Schairer C, Harford JB, Hablas A, Ramadan M, et al. Breast Cancer by Age at Diagnosis in the Gharbiah, Egypt, Population-Based Registry Compared to the United States Surveillance, Epidemiology, and End Results Program, 2004-2008. BioMed Research International 2015;2015:9.
  7. Hatem A Azim and Ann H Partridge. Biology of breast cancer in young women. Breast Cancer Research 2014, 16:427.
  8. batori, M. Ruggieri, E. Chtelou, A. Straiero, G. Mariotta, L. Palombi, G. Casella, M. Basile, M.C. Casella. Breast cancer in young women: case report and review. European Review for Medical and Pharmacological Sciences. 2006; 10: 51-52.
  9. PunamRana, Jenna Ratcliffe, Jonathan Sussman, Margaret Forbes, Mark Levine and Nicole Hodgson. Young women with breast cancer: Needs and experiences. Cogent Medicine (2017), 4: 1278836.
  10. Assi HA, Khoury KE, Dbouk H, Khalil LE, Mouhieddine TH, El Saghir NS. Epidemiology and prognosis of breast cancer in young women. J Thorac Dis 2013;5( 1):S2-S8.
  11. Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, et al. Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression. Journal of Clinical Oncology 2008;26(20):3324-30.
  12. Shannon C, Smith IE. Breast cancer in adolescents and young women. Eur J Cancer 2003;39(18):2632-42.
  13. AH. IN2,Breast Cancer in Young Women: A rare disease or a significant public health problem? the breast 2014;23:s1.
  14. Love RR, Duc NB, Van Dinh N, Quy TT, Xin Y, Havighurst TC. Young age as an adverse prognostic factor in premenopausal women with operable breast cancer. Clinical Breast Cancer 2002;2(4):294-8.
  15. FredholmH,MagnussonK,lindstromSL,GarmoH,EakarS,Lindman H et al. HM31 breast cancer in young women-age a risk factor only in those not given chemotherapy. the breast 2014;23(1):S12.
  16. Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. Journal of the American College of Surgeons 2009;208(3):341-7
  17. Elkum N, Dermime S, AjarimD,Al-Zahrani A, AlsayedA,TulbahA,et al. Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients. BMC cancer 2007; (5):222.
  18. Song YJ, Shin SH, Cho JS, Park MH, Yoon JH, Jegal YJ. The role of lymphovascular invasion as a prognostic factor in patients with lymph node-positive operable invasive breast cancer. Journal of breast cancer 2011;14(3):198-203.
  19. Cancello G, Maisonneuve P, Rotmensz N, Viale G, Mastropasqua MG, Pruneri G, et al. Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol 2010; 21(10):1974-81.
  20. Alieldin NH, Abo-Elazm OM, Bilal D, Salem SE, Gouda E, Elmongy M, et al. Age at diagnosis in women with non-metastatic breast cancer: Is it related to prognosis? Journal of the Egyptian National Cancer Institute 2014;26(1):23-30.
  21. Wang K RY, Li H, Zheng K, Jiang J, Zou T, et al. Comparison of Clinicopathological Features and Treatments between Young (≤40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only Study. . PloS one (2016);11(3): e0152312.
  22. Kataoka A, Iwamoto T, Tokunaga E, Tomotaki A, Kumamaru H, Miyata H, et al. Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry. Breast Cancer Research and Treatment 2016;160(1):163-72.
  23. Zhang Q, Ma B, Kang M. A retrospective comparative study of clinicopathological features between young and elderly women with breast cancer. International Journal of Clinical and Experimental Medicine 2015;8(4):5869-75.
  24. Morrison D, Rahardja D, King E, Peng Y, Sarode V. Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer. British journal of cancer 2012;107(2):382-7.
  25. Kim E-K, Noh WC, Han W, Noh D-Y. Prognostic significance of young age (< 35 years) by subtype based on ER, PR, and HER2 status in breast cancer: a nationwide registry-based study. World Journal of Surgery 2011;35(6):1244-53.
  26. Celikmakas E, Karslioglu Y, Hacibey I, Kilic S, Ozturk M, Safali M, et al. HER2 positivity is high in breast cancer of young women: Experience of a single institute in Turkey. European journal of cancer 2016;61: S171.
  27. Ariga R, Bloom K, Reddy VB, Kluskens L, Francescatti D, Dowlat K, et al. Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation. The American Journal of Surgery 2002;184(5):410-3.

How to Cite This Article

H. Fayed, A. T. Awed and Azza Darweesh. (2019); AGE AS AN INDEPENDENT PROGNOSTIC FACTOR IN BREAST CANCER., Int. J. of Adv. Res., 7 (04), 1601-1607, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/8989

Corresponding Author

Haytham Fayed
Assistant professor, Alexandria Faculty of Medicine, Alexandria University
Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.